Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patients.

A Sgambato, M Begemann, Y Doki, H Yamamoto, E K Han, M Ciaparrone, N Arber, I B Weinstein, P Zhou, Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clinical Cancer Research. ,vol. 3, pp. 2696- 2702 ,(1997)

M. Aoki, H. Jiang, P. K. Vogt, Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 13613- 13617 ,(2004) , 10.1073/PNAS.0405454101

Consuelo Gajate, Faustino Mollinedo, The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells Blood. ,vol. 98, pp. 3860- 3863 ,(2001) , 10.1182/BLOOD.V98.13.3860

Effat S Emamian, Diana Hall, Morris J Birnbaum, Maria Karayiorgou, Joseph A Gogos, Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nature Genetics. ,vol. 36, pp. 131- 137 ,(2004) , 10.1038/NG1296

Louis J. Lombardo, Francis Y. Lee, Ping Chen, Derek Norris, Joel C. Barrish, Kamelia Behnia, Stephen Castaneda, Lyndon A. M. Cornelius, Jagabandhu Das, Arthur M. Doweyko, Craig Fairchild, John T. Hunt, Ivan Inigo, Kathy Johnston, Amrita Kamath, David Kan, Herbert Klei, Punit Marathe, Suhong Pang, Russell Peterson, Sidney Pitt, Gary L. Schieven, Robert J. Schmidt, John Tokarski, Mei-Li Wen, John Wityak, Robert M. Borzilleri, Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. Journal of Medicinal Chemistry. ,vol. 47, pp. 6658- 6661 ,(2004) , 10.1021/JM049486A

Heng Wu, Vikas Goel, Frank G Haluska, PTEN signaling pathways in melanoma Oncogene. ,vol. 22, pp. 3113- 3122 ,(2003) , 10.1038/SJ.ONC.1206451

Andreas G Bader, Sohye Kang, Li Zhao, Peter K Vogt, None, Oncogenic PI3K deregulates transcription and translation. Nature Reviews Cancer. ,vol. 5, pp. 921- 929 ,(2005) , 10.1038/NRC1753

Janet E. Dancey, Therapeutic targets: MTOR and related pathways. Cancer Biology & Therapy. ,vol. 5, pp. 1065- 1073 ,(2006) , 10.4161/CBT.5.9.3175

A Oloumi, S Syam, S Dedhar, Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells. Oncogene. ,vol. 25, pp. 7747- 7757 ,(2006) , 10.1038/SJ.ONC.1209752

Gerald A. Ruiter, Shuraila F. Zerp, Harry Bartelink, Wim J. van Blitterswijk, Marcel Verheij, Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase–Akt/PKB survival pathway Anti-Cancer Drugs. ,vol. 14, pp. 167- 173 ,(2003) , 10.1097/00001813-200302000-00011